Nanoparticles as a formulation platform for bioavailability-challenged molecules

Our Chief Technology Officer, Pascale Clement, spoke at the Formulation & Delivery Series UK virtual event on July 8 2020 to provide delegates with an overview of nanoparticles as a formulation platform for bioavailability-challenged molecules, highlighting the benefits of leon’s proprietary technology in characterisation and rapid scale-up from bench to clinic.

© leon-nanodrugs GmbH 2020
DisclaimerPrivacy PolicySite Notice